Is atrial fibrillation an inflammatory disorder?

Area of Science:

• Cardiology
• Immunology
• Pharmacology

Background:

• Atrial fibrillation (AF) pathogenesis is increasingly linked to inflammation.
• Elevated inflammatory markers and atrial inflammation are observed in AF patients.
• The renin-angiotensin-aldosterone system (RAAS) is implicated in AF-related inflammation.

Purpose of the Study:

• To review the evidence linking inflammation to AF.
• To explore potential therapeutic strategies for AF prevention by modulating inflammation.

Main Methods:

• Review of existing scientific literature on inflammation and AF.
• Analysis of studies on drug therapies affecting inflammatory pathways.

Main Results:

• Strong evidence supports inflammation's role in AF.
• RAAS significantly contributes to AF pathogenesis via inflammation.
• Preliminary data suggest efficacy of certain drugs in AF prevention.

Conclusions:

• Inflammation is a critical factor in AF development.
• Targeting inflammatory pathways with drugs like ACE inhibitors, ARBs, steroids, fish oils, and vitamin C shows promise for AF prevention.